Charlotte Pawlyn

Sad that @EHA_Hematology #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!

@drlaurajane @BTSrespiratory This is amazing! I’m thinking “blood cell” Heads Up would be a close second 😉 Have fun at BTS.

At #BTSSummer2024? Come and play inhalers Heads Up at the @BTSrespiratory stall!

What is ⁦@EHA_Hematology⁩ Clinical Research Training in #Hematology (CRTH)? #CRTH provides early-career researchers with a unique, 9-month long training and mentoring experience. The CRTH 2025 call for applications is open until August 30, 2024 search.app/383eipgfnc8AdX…

@HiraSMian @VincentRK @RaabMarc @ResearchMyeloma @MyelomaCanada @AnnetteHay1 Very excited and grateful to be coming to 🇨🇦 - I think we have a lot to learn from you too - many similarities between 🇬🇧 and 🇨🇦 health systems!

We look forward to hosting @VincentRK @_DrCP and @RaabMarc in Canada this year to learn some pearls with @ResearchMyeloma @MyelomaCanada @AnnetteHay1

Always so impressed by other cooperative groups executing large phase III trials including IFM, HoVOn, UK etc… we need more funding in Canada to build clinical trial infrastructure @ResearchMyeloma @MyelomaCanada @CDNCancerTrials @ECRI_RESEARCH @McMasteResearch @HamHealthSci

@abrioli @Nory4 @DrLMelchor @DrGarethMorgan1 @FaithEDavies1 @sci_bri Great to hear from you @nory4! Hope all going well 😊

@Nory4 @DrLMelchor @_DrCP @DrGarethMorgan1 @FaithEDavies1 @sci_bri Would be great!

ICR Myeloma team reunited. @DrLMelchor @_DrCP we missed you @DrGarethMorgan1 @FaithEDavies1 @sci_bri #EHA2024

📣 Our Early Career Advancement Fellowships are officially open for applications! 📣 These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/fundi…

@abrioli @DrLMelchor @DrGarethMorgan1 @FaithEDavies1 @sci_bri 2024 or 2014?! Great to catch up @DrLMelchor and @abrioli 😊

.@mvmateos makes a very important point - Frailty score is dynamic! It’s important to reassess frailty- bone pain and renal impairment may change with treatment. Frailty is not one and done. #mmsm #EHA2024

@EilidhMDuncan Really thought provoking session and great work from @MyelomaEurope

From learning new #clinicaltrial skills to developing your own research project, #EHA Clinical Research Training in Hematology (#CRTH) is a chance to advance your #hematology career. Hear from C Lecat, past CRTH scholar about her experience 👇 Learn more: eha.fyi/CRTH25

There will be opportunities to contribute to T- cell directed therapy service expansion and be involved in / lead clinical research - working with a great team! Feel free to free to contact me for further information or apply at link above.

We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre. royalmarsden.nhs.uk/current-vacanc…

Great new tool for patients presented by @MyelomaEurope at #EMN2024

Great session at #EMN2024 from patient organisations @IMFmyeloma and @MyelomaEurope

Not sure if you can submit an abstract and join #EHA2024? If you are under 36, you may qualify for a travel or participation grant. Grant applications are available during regular abstract submission and close on March 1, 2024. Submit an abstract: eha.fyi/EHA2024_abstra…

Presenting the work of Dr Yigen Li from my lab @ICR_London at #ASH2023

@YakinthiC presenting her work on CRBN mutations and IMID/CeLMOD response at #ASH2023 👏👏 @ICR_London

Should have added @kennycairns @Orla_McCourt 😊

Exciting initial HRQoL data from the FiTNEss trial. @CTRUmyeloma @profBigG @profghjackson @LeedsCTRU

#MyXAnniversary joined at #ASH2012 ….now at #ASH2023